SUMMARY. Somatomedin-C, a peptide growth factor that is also termed insulin-like growth factor I, stimulates smooth muscle cell replication; however, these cells proliferate in somatomedin-C-deficient medium. We postulated, therefore, that these cells might release a somatomedin-like molecule into the surrounding culture medium. Porcine aortic smooth muscle cells that were exposed to serum-free Dulbecco's modified minimum essential medium for 24 hours were found to release a somatomedin-like molecule that could be detected by a specific radioimmunoassay for somatomedin-C. Several variables in the design of tissue culture conditions were found to regulate the secretion of the somatomedin-like peptide. There was an inverse relationship between somatomedin-like peptide secretion and culture density. Cultures grown to a density of 110,000 cells/well secreted 0.18 ± 0.02 U/ml per 10 5 cells, whereas cultures grown to 38,000 cells/well secreted 0.59 ± 0.06 U/ml per 10 5 cells (P < 0.001). Serum deprivation and days of preincubation before initiation of an experiment were found to influence somatomedin-like peptide secretion significantly. Platelet-derived growth factor, which stimulates smooth muscle cell replication, was a potent stimulant of somatomedin-like peptide secretion. Exposure to a concentration of 500 ng/ml platelet-derived growth factor induced a 2.8-fold increase in somatomedin-like peptide secretion over basal levels, (i.e., 0.37 ± 0.05 to 0.98 ± 0.7 U/ml, P < 0.001). The effect of plateletderived growth factor was enhanced (41% increase) by concomitant incubation with 1% somatomedin-C-deficient platelet poor plasma. Transient exposure to platelet-derived growth factor followed by exposure to 1% somatomedin-C-deficient platelet-poor plasma caused a sustained increase in somatomedin-like peptide production even after platelet-derived growth factor had been removed from the culture dish. In contrast to platelet-derived growth factor, hormones and growth factors that circulate in plasma and do not stimulate smooth muscle cell replication after transient exposure, did not stimulate quiescent cultures to secrete the somatomedin-like peptide. However, if the cultures were transiently exposed to platelet-derived growth factor, then exposed to either insulin, epidermal growth factor, or thyroxine, each stimulated somatomedin secretion. Since these hormones were inactive when added to quiescent cultures, it is postulated that entry into the cell cycle is required to achieve stimulation with these substances. The production of this somatomedin-like peptide may be linked to smooth muscle cell replication, since many factors which stimulate replication also facilitate production and release of this material. (Circ Res 56: 418-426, 1985) 
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Previous studies have reported that cultured human fibroblasts can proliferate in medium that is deficient in Sm-C/IGF-I; however, Sm-C/IGF-I stimulates fibroblast replication (Moses et al., 1978; Clemmons and Van Wyk, 1981b) . These discrepant observations were clarified when it was reported that cultured fibroblasts produced a peptide growth factor that had biological and immunochemical characteristics similar to Sm-C/IGF-I (Atkison et al., 1980) . Secretion of the somatomedin-like pepride by fibroblasts has been shown to be stimulated by human growth hormone and PDGF. Since smooth muscle cells have growth factor requirements similar to those of fibroblasts, and can proliferate in medium that is deficient in Sm-C, these studies were undertaken to determine whether cultured porcine aortic smooth muscle cells produce a somatomedin-like peptide. A secondary purpose was to determine whether other growth factors, such as PDGF, could stimulate the production and release of this substance.
Methods
Porcine aortic smooth muscle cells were isolated from young piglets by a previously published method (Ross, 1971) . The abdominal aorta was removed from a 3-weekold animal, and the tissue was dissected to remove the endothelium and adventitia. Explants (2x2 mm) of the remaining subendothelial tissue were washed twice with PBS, then plated in 10-cm dishes (Falcon 3001, Falcon Labware Division, Becton Dickinson) in Dulbecco's modified Eagle's medium (DMEM) (Flow laboratories) supplemented with 10% fetal calf serum (FCS), (Grand Island Biological Company) (GIBCO), penicillin (100 U/ml), and streptomycin (100 Mg/m') (GIBCO). After a 2-week incubation period, the cells that had migrated from the explants were removed by trypsinization (0.5% trypsin, 0.02% EDTA) (GIBCO) and replated, using a split ratio of 1:3, in the same medium. Stock cultures were maintained in a humidified incubator containing 5% CO2. The medium was changed every 3rd day until growth was confluent (usually 8-11 days). At that time, the cells were harvested by trypsinization and replated (passage dilution 1:4). Plating efficiences were determined to be greater than 88% for each trypsinization. All stock cultures were tested for mycoplasma contamination and were not contaminated (Chen, 1977) . Cultures between the 4th and 9th passage were used in all the experiments.
Preparation of Growth Factors
Human Sm-C/IGF-I used for iodination in these studies was purified to homogeneity as determined by multiple criteria; and was a gift of Dr. Judson J. Van Wyk. Epidermal growth factor was purchased from Collaborative Research. Porcine insulin (lot #PJ5682) was a gift from the Eli Lilly Company. PDGF was purified by modification of previously described methods (Antoniades et al., 1979; Heldin et al., 1979) . The material had an activity of approximately 1800 U/mg, 1 unit being equal to the quantity of PDGF necessary to stimulate nuclear labeling equal to 10% human serum. This PDGF preparation was estimated to be 14% pure. The PDGF preparation was tested for Sm-C content and, at a PDGF concentration of 50 ^g/ml, there was no cross-reactivity with anti-Sm-C antibody. Somatomedin-C-deficient PPP was. obtained from growth hormone-deficient donors by placing freshly 419 drawn blood into prechilled (4°C) plastic tubes. The plasma was prepared by a previously described method . The Sm-C/IGF-I content was less than 4 ng/ml. The platelet factor 4 content of this plasma was less than 15 ng/ml by radioimmunoassay (White and Marouf, 1981) .
Determination of Somatomedin-like Peptide Secretion
Porcine aortic smooth muscle cells were subcultured in 24 multiwell plates (Falcon 3008) in DMEM containing 10% FCS, with a plating density of 7000 cells/cm 2 , unless otherwise noted. The medium was changed after 3 days, and confluent growth was reached after an additional 3-4 days of incubation. Before each experiment, serumcontaining medium was removed by aspiration, the cells were washed three times with 0.5 ml serum-free DMEM [no immunoreactive somatomedin (Sm) was detected in the third wash], and the cultures were exposed to 0.5 ml of this medium. The duration of incubation in serum-free DMEM was 24 hours, unless otherwise noted. If cell density was the variable to be tested, the cells were plated at densities varying between 8,000 and 90,000 cells/well and cultured for 3 days. At that time, they were washed extensively and exposed to 0.5 ml of serum-free DMEM for 24 hours. After aspiration of the medium, the cells were detached by trypsinization and the cell number was determined in triplicate wells, with a particle data counter (Coulter model #ZBI). If the days since a prior medium change or plating was a variable to be tested, DMEM containing 10% FCS was added to cultures 3 days after plating, and the incubation continued without a further medium change until the day the experiment was to be performed.
Quantification of Immunoreactive Somatomedin-like Peptide Content in Medium
Medium samples for Sm-like peptide determination were removed at the rime indicated, and each sample was stored at -20°C until it was assayed. The samples were prepared for radioimmunoassay by a previously described method (Clemmons etal., 1981) . Pure Sm-C/IGF-I, 10,000 U/mg, was iodinated to a specific activity between 140 and 210 ^Ci/Mg and purified by affinity chromatography. The radioimmunoassay used anti-human Sm-C/IGF-I antibody at a final dilution of 1 to 12,000 (Copeland et al., 1980) . This assay is highly specific for Sm-C/IGF-I and shows little cross-reactivity with somatomedin-A, MSA, and IGF-II (Van Wyk et al., 1979) . The radioimmunoassay was performed with 0.5% Tween detergent in the assay buffer. Under these conditions, dose-response curves obtained with unextracted conditioned medium were parallel to pure Sm-C/IGF-I standard. In addition, recovery of pure Sm-C/IGF-I from the medium preparation was 77%; therefore, the quantity of the somatomedinlike peptide that was present was slightly underestimated. Binding of [I]Sm-C/IGF-I to the smooth muscle cells was measured by a previously described method (Clemmons et al. 1981) .
A partially purified preparation of the somatomedinlike peptide was prepared by the following method. Subconfluent cultures were washed and exposed to serumfree DMEM for 24 hours, and the medium aspirated was then concentrated by ultrafiltration, with an Amicon YM-5 membrane. The pooled concentrates from 500 ml of medium were dialyzed against 10 liters of 0.05 M Tris buffer, pH 5.0. CM Sephadex (1 g) was added to the dialysate, and the mixture was stirred overnight at 4°C. The mixture was poured into a 5 X 10 cm column, and the column was washed with three column volumes of 0.05 M Tris, pH 6.5, at 2.0 ml/min. The proteins were eluted using a linear NaCl gradient (0.1-1.0 M) in 0.05 M Tris, pH 8.0, at 1.0 ml/min. The somatomedin content of each 3.0-ml fraction was determined by RIA, and the active fractions were pooled, dialyzed, and lypophilized to dryness. The residue was reconstituted in 4.0 ml of 0.05 M ammoniun acetate, pH 3.7, containing 1% CHAPS detergent and applied to a 1.6 X 110 cm Sephadex G-150 column. The column was eluted with the same buffer at a flow rate of 13 ml/hr, and the active fractions were determined. The biological activity of the partially purified Sm-like peptide was determined by transiently exposing confluent, quiescent BALB/c 3T3 fibroblasts to PDGF (50 ng/ml) for 5 hours, followed by 5% Sm-C/IGF-I-deficient PPP and test quantities of pure Sm-C/IGF-I or the partially purified Sm-like peptide. After a 36-hour^ incubation, [H]thymidine incorporation was determined as previously described (Clemmons and Shaw, 1983) . Under these conditions, BALB/c 3T3 fibroblasts are sensitive to the effects of Sm-like growth factors, but this bioassay is not specific for somatomedins.
Results
Quiescent, confluent porcine aortic smooth muscle cells secreted a peptide* into the medium in a quantity sufficient to be detected by the Sm-C radioimmunoassay. The release of this peptide into the medium was associated with a progressive increase for approximately 72 hours; it plateaued, thereafter, and no further increase over time was noted beyond that point (Table 1) . To eliminate the possibility that the cells had taken up Sm-C from the FCS and released it during the 72-hour incubation, the following experiments were performed. The media were changed at 12-hour intervals for a 72-hour incubation period, the Sm-like peptide content was determined, and the results were summed. Although there was no significant increase in the apparent immunoreactive Sm-Iike peptide concentration compared to cultures incubated continuously for 72 hours, the immunoreactive Sm-like peptide concentration that was released was 2.4-fold greater than that present in 10% FCS (Table 1) . Additional cultures were incubated with cycloheximide (50 ^M) for 72 hours. As shown in Table 1 , the cultures exposed to cycloheximide had no detectable immunoreactive Sm-like material. In another experiment, triplicate cultures were preincubated in MEM containing 10% Sm-C/IGF-I-deficient serum (final concentration = 0.2 ng/ml) for 3 days. The quantity of Sm-like peptide that was released was 22% greater than cultures exposed to 10% FCS. In addition, when [ 12S I]Sm-C/IGF-I (2 ng/ml) was exposed to the cultures for 48 hours at 37°C, then removed and reexposed to fresh cells, specific binding of the labeled peptide had been reduced by greater than 90%, indicating that most of the growth factor had been degraded.
Since PDGF is a potent stimulant of porcine aortic smooth muscle cell replication, it was of interest to determine the effect of this growth factor on Smlike peptide production. Increasing concentrations of partially purified PDGF, that had no detectable Sm-C by radioimmunoassay, were added to quiescent smooth muscle cell cultures, and secretion of the Sm-like peptide was determined (Fig. 1) . Under basal conditions, the cultures released 0.37 ± 0.05 U/ml in 24 hours, and this increased to 0.98 ± 0.07 U/ml when exposed to 500 ng/ml partially purified PDGF. Even at the lowest concentration of PDGF used (i.e., 62.5 ng/ml), there was a statistically significant (P < 0.05), increment in the concentration of Sm-like peptide released by the PDGF-treated cultures when compared to the nonstimulated cultures. Repetition of this experiment using pure PDGF (obtained from Cellular Products) showed that pure material could stimulate a 3.4-fold increase in Sm-like peptide release at a concentration of 14 ng/ml.
Increasing culture density is associated with a diminution in the growth rate of porcine aortic smooth muscle cells. To determine whether changes in Sm-like peptide secretion were associated with changes in culture density, smooth muscle cell cultures were plated at densities varying between 15,000 and 70,000 cells/well, and 3 days after plating, Sm-like peptide secretion was determined. Cell density had a significant effect on somatomedin secretion (Fig. 2) . The basal secretion decreased from 0.58 ± 0.06 U/ml at 28,000 cells/well to 0.21 ± 0.05 U/ml at 110,000 cells/well (P < 0.001). Additionally, the effect of PDGF was attenuated by high culture density, although the percent stimulation inducible by PDGF increased as the culture density increased. To document the reproducibility of this relationship, we performed 11 experiments on separate days, using separate 24-well plates that had been plated at different culture densities. The basal rate of somatomedin secretion was compared for each density; cell density is plotted as function of somatomedin-like peptide concentration (Fig. 3) . There was a highly significant correlation between density and Sm-like peptide secretion, r = 0.88, P < 0.01.
Other parameters that significantly influence somatomedin secretion are listed in Figure 1 . The results are expressed as the mean of triplicate well ± 1 sa the day of the last medium change had an effect on the release of the Sm-like peptide from the cells. Smooth muscle cells were plated at a high density between 1.12 X 10 5 cells/well in DMEM supplemented with 10% FCS. After incubation intervals of between 3 and 10 days without a medium change, the cultures were washed and exposed to serumfree DMEM for 24 hours. Each incubation interval between days 5 and 10 showed statistically significant increments in Sm-like secretion, compared to day 3 cultures, and by day nine there had been a Figure 1 . Results are expressed as mean ± 1 SD.
• Compared to day 3, P < 0.01.
2.9-fold increase in the Sm-like peptide concentrations. To determine whether this increase was due to serum deprivation, smooth muscle cell cultures were preincubated for 3 days in DMEM supplemented with either 0.5% or 10% FCS. The cultures that had been incubated in 0.5% FCS had a 49% increase in Sm-like peptide secretion. Since a 2.9-fold increase was demonstrable after 9 days in culture, the effect of time in culture appeared to predominate. Other parameters that were examined were passage number, number of medium changes during the first 48-hour incubation period, and the effect of protease inhibitors. None of these appeared to have statistically significant effects on Sm-C secretion (data not shown).
Multiple growth factors that circulate in plasma were tested for their capacity to stimulate the secretion of this peptide. When incubated in the presence of Sm-C deficient PPP, epidermal growth factor, thyroxine, and insulin all failed to induce significant increments in Sm-like peptide secretion (Fig. 4, left  panel) . In contrast, if PDGF (100 ng/ml) and 0.5% Sm-C-deficient PPP were co-incubated with each of these factors, each substance induced a statistically significant increment in Sm-like peptide secretion. The variables that were necessary for insulin to be an effective stimulant were analyzed, using two different experimental designs. Quiescent cells were transiently exposed to PDGF followed by Sm-Cdeficient PPP, plus increasing concentrations of insulin. Compared to identical cultures that were transiently exposed to PDGF followed by insulin in serum-free DMEM, there was a marked increase in the concentration of Sm-like peptide that was released (Fig. 5) . This suggests that other factors in Sm-C deficient PPP are required to obtain the maximal stimulation of Sm-like peptide secretion. However, since the combination of insulin plus Sm-Cdeficient PPP (Fig. 4, left panel) caused no increase in Sm-like peptide secretion, it appears that these factors are active only in cells that had prior exposure to PDGF. To analyze this dependency upon PDGF exposure further, 500 ng/ml of PDGF were added to quiescent smooth muscle cells simultaneously with 1% Sm-C-deficient PPP and variable concentrations of insulin. There was a concentration-dependent increase in the amount of Sm-like peptide secreted in response to insulin (Fig. 6) . In contrast, when the cultures were exposed to epidermal growth factor (20 ng/ml) and 1% Sm-C-deficient PPP, the rate of Sm-like peptide secretion following stimulation by identical concentrations of insulin was greatly reduced.
To determine whether the Sm-like peptide that was secreted was biologically active we tested a partially purified preparation of this material for its capacity to stimulate replication in BALB/c 3T3 fibroblasts. For comparison, additional cultures received 5% Sm-C/IGF-I-deficient PPP and increasing concentrations of pure Sm-C/IGF-I. The Sm-like peptide stimulated significant increases in DNA synthesis (Table 3) . Based on RIA units, the most highly Insulin (ng/ml) Insulin (ng/ml) purified material was less potent than pure Sm-C/ IGF-I.
Discussion
Sm-C/IGF-1 stimulates replication in multiple types of cultured cells, including smooth muscle cells (Pfeifle et al., 1982) . The observation that smooth muscle cells can replicate in medium that is deficient in Sm-C/IGF-I, however, raised an important question. Was this growth factor required for smooth muscle cell replication? Like smooth muscle cells, cultured human fibroblasts are capable of replicating in Sm-C/IGF-I-deficient medium. Fibroblasts produce a growth factor with immunochemical and biological properties similar to Sm-C (Clemmons et al., 1981) , and it has been proposed that the secretion of this peptide enables fibroblasts to replicate in Sm-C-deficient medium (Clemmons and Van Wyk, 1981) . In addition, the production of the Smlike peptide by fibroblasts can be stimulated by other growth factors, such as PDGF, and this appears to be one mechanism by which PDGF can stimulate fibroblast replication.
Since smooth muscle cells have some growth characteristics that are similar to fibroblasts, these experiments were conducted to determine whether they secreted an Sm-like peptide. Both quiescent and smooth muscle cells that had been stimulated to enter the cell cycle released into the medium a peptide that has immunochemical properties similar to Sm-C/IGF-I. The results support the conclusion that the smooth muscle cell cultures are producing a Sm-C/IGF-I-like peptide and are not just taking it up from fetal calf serum and releasing it into the medium, although the results provide only indirect evidence of synthesis. Attempts to confirm biosynthesis of the peptide using radiolabeled amino acids have been unsuccessful, due to the small amount of Sm-like peptide that secreted relative to the total amount of protein.
The material that is secreted is a peptide. The partially purified peptide is biologically active and mimicks the effect of pure Sm-C/IGF-I, using the BALB/C 3T3 cell bioassay test system. The BALB/C 3T3 cell bioassay test system is not specific for Sm-C, and it is possible that a mitogen that co-purifies with the Sm-like peptide could account for the bioactivity. Recent studies in our laboratory have demonstrated that addition of a specific monoclonal anti-Sm-C antibody that binds the Sm-like peptide to PDGF-stimulated smooth muscle cell cultures results in inhibition of [ 3 H]thymidine incorporation (Clemmons and Van Wyk, personal communication) . Since the antibody binds specifically to Sm-C and to the partially purified Sm-like peptide, this finding strengthens our conclusion that the Sm-like peptide is the active component of the partially purified material. These observations support the conclusion that the secreted form of this material may act locally to stimulate smooth muscle cell replication.
Further support for the hypothesis that the release of this peptide is closely linked to the control of smooth muscle cell replication is provided by analysis of the variables that control its release. Highdensity cultures were shown to release decreased amounts of Sm-like peptide per cell. The mechanism for this decrease is unknown. It is possible that diminished Sm-like peptide production at high density merely reflects a diminution in the rate of total cellular protein synthesis (Levine et al., 1965) . Our laboratory has previously reported that Sm-like peptide production per cell was reduced 4-fold in highdensity fibroblasts cultures, whereas there was only a 1.7-fold reduction in total protein synthesis (Clemmons and Shaw, 1983) . Cultures at high density also have diminished rates of pinocytosis (Davies and Ross, 1980) , decreased peptide growth factor receptors (Holley et al., 1977) , and decreased proteoglycan accumulation (Peitilia and Nakkari, 1982) . It is possible that reduction in Sm-C secretion per cell in high-density cultures is part of a more generalized metabolic response to confluent growth.
Time in culture and serum deprivation were important modulators of Sm-like peptide secretion. Time in culture was relatively more important, but both parameters need to be standardized to permit valid comparisons between the results of two or more experiments. Serum deprivation prior to initiation of an experiment leads to increased rates of replication after the addition of fresh serum supplements or growth factors (Pledger et al., 1978) . The enhanced rates of Sm-like peptide secretion noted in these studies after serum deprivation may be linked to this increase in replication.
Paritally purified PDGF was a potent stimulant of Sm-like peptide secretion. Likewise, pure PDGF was stimulatory, indicating that PDGF is an important component of the biological activity in our partially purified preparations. This study did not determine whether this effect of PDGF was specific for the Sm-like peptide. Since PDGF stimulates the synthesis of many cellular proteins, it is possible that this effect is related to this general property of PDGF. High-density cultures could also be stimulated by PDGF exposure. Previous studies have shown that maximal cell density is directly proportional to PDGF concentration in the medium (Vogel et al., 1980) . It is possible that stimulation of Sm-like peptide secretion by PDGF in high-density cultures is a mechanism by which PDGF can overcome the negative effects of culture density on cell growth.
PDGF causes rapid initiation of ion and amino acid transport (Owen et al., 1982) and an immediate increase in the rates of protein synthesis in cultured cells (Cochran et al., 1981) . Since PDGF is capable of stimulating quiescent smooth muscle cells to enter the cell cycle (Rutherford and Ross, 1976) , it is possible that stimulation of Sm-like peptide secretion by PDGF is one of the early events that lead to cell cycle entry. Conversely, since transient exposure to PDGF followed by exposure to Sm-C-deficient plasma leads to a sustained increase in Sm-like peptide secretion, the PDGF-induced increase may be secondary to the fact that the cells are no longer quiescent, and in that state will intrinsically secrete more Sm-like peptide. However, continuous exposure of cycling cells to PDGF is definitely associated with higher rates of Sm-like peptide secretion, suggesting that PDGF is continuing to stimulate the synthesis of this Sm-like material, even in cycling cells.
Cell cycle timing is an important determinant of the DNA synthesis response of cells to growth factors contained in plasma. In this study, none of the plasma growth factors could stimulate Sm secretion without simultaneous exposure to PDGF. This finding suggests that smooth muscle cells must leave the quiescent state to be able to increase Sm-like peptide secretion in response to these growth factors and hormones. Whether these factors act to stimulate a PDGF-dependent effect on Sm-like peptide secretion, or whether they are effective simply because the cells have been stimulated to enter the cell cycle, cannot be determined from these studies.
Detailed chemical analysis of the Sm-like peptide was not carried out in these studies; however, the peptide has immunochemical properties similar to Sm-C, since it cross-reacts with both polyclonal antisera used in these studies and a highly specific monoclonal anti-Sm-C antibody. These results imply structural homology at several antigenic sites. Studies of the biological response to this peptide show that the partially purified peptide is biologically active and the activity is retained through two purification steps. Based upon RIA units, its activity is comparable to pure human Sm-C/IGF-I, although-due to probable species differences in the primary structure-an exact equivalent relationship cannot be determined. Furthermore, until molecular weight and isoelectric point determinations are made, it will not be possible to know the exact chemical relationship between this growth factor and Sm-C/IGF-I.
Several investigators have reported the production and release into the medium of growth factors by cells maintained in tissue culture. Dulak and Temin (1973) and, more recently, Nissley and Rechler (1977) have reported the production of rat somatomedin (MSA) by cultured buffalo rat liver cells. Acquaviva et al. (1982) have used this system to study the biosynthesis of this somatomedin-like peptide. Although several studies have reported the conditioning of medium by the cellular secretion of growth factors (Young et al., 1975; Millis et al., 1978) this phenomenon has taken on new significance with the proposal of a model for the autocrine regulation of cell growth. Delarco and Todaro (1978) have reported that spontaneously and virally transformed cell lines have the capacity to secete transforming growth factors into the medium. More importantly, they and others (Kaplan and Ozanne, 1982) have demonstrated that these peptides can regulate cell growth. Several investigators have reported the production of specific growth factors by cultured fibroblasts (Atkison et al., 1980; Clemmons et al., 1981) , and recently Canalis et al. (1980) have reported the production of growth factors by normal cartilage and bone cells. These studies support the hypothesis that the smooth muscle cell is an additional cell type that is capable of autocrine growth regulation.
Analysis of the mechanisms that control the secretion of these factors may have important implications for understanding fundamental biochemical reactions that control the response to vascular wall injury and the development of atherosclerosis. Since PDGF release appears to be an important component of the acute response to vascular injury, it is possible that the rapid increase in Sm-like peptide release induced by PDGF is a growth regulatory event. Secretion of this material in selective areas could stimulate regional proliferation of the subendothelium and leave areas adjacent to the injury unaffected. Therefore, the elucidation of the factors that control this somatomedin autocrine regulatory system may further our understanding of atherosclerosis.
